Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia-Reference-Cited by-同舟云学术

Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

Published:2011-08-18 Issue:2 Volume:155 Page:182-189
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Becker Pamela S.,Kantarjian Hagop M.,Appelbaum Frederick R.,Petersdorf Stephen H.,Storer Barry,Pierce Sherry,Shan Jianqin,Hendrie Paul C.,Pagel John M.,Shustov Andrei R.,Stirewalt Derek L.,Faderl Stephan,Harrington Elizabeth,Estey Elihu H.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08831.x/fullpdf

Reference34 articles.

1. Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older;Bashey;Leukemia Research,2006

2. Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine;Braess;British Journal of Haematology,2000

3. Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia;Braess;British Journal of Haematology,2001

4. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;Journal of Clinical Oncology,2005

5. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy;Burnett;Journal of Clinical Oncology,2010

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?;Journal of Clinical Medicine;2024-01-18

2. Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study;Expert Review of Hematology;2022-08-04

3. Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML;Blood Advances;2022-04-25

4. A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial;British Journal of Haematology;2022-04-06

5. Advances in acute myeloid leukemia;BMJ;2021-10-06